Whole Genome Sequencing in Pharmacogenomics

Overview

Journal Front Pharmacol

Date 2015 Apr 11

PMID 25859217

Citations 20

Authors

Theodora Katsila

George P Patrinos

Affiliations

Soon will be listed here.

Abstract

Pharmacogenomics aims to shed light on the role of genes and genomic variants in clinical treatment response. Although, several drug-gene relationships are characterized to date, many challenges still remain toward the application of pharmacogenomics in the clinic; clinical guidelines for pharmacogenomic testing are still in their infancy, whereas the emerging high throughput genotyping technologies produce a tsunami of new findings. Herein, the potential of whole genome sequencing on pharmacogenomics research and clinical application are highlighted.

Citing Articles

High-coverage whole-genome sequencing of a Jakun individual from the "Orang Asli" Proto-Malay subtribe from Peninsular Malaysia.

Yap W, Cengnata A, Saw W, Abdul Rahman T, Teo Y, Lim R Hum Genome Var. 2025; 12(1):4.

PMID: 39774017 PMC: 11707147. DOI: 10.1038/s41439-024-00308-6.

Utilizing Pharmacogenomic Data for a Safer Use of Statins among the Emirati Population.

Alqasrawi M, Al-Mahayri Z, Alblooshi H, AlSafar H, Ali B Curr Vasc Pharmacol. 2024; 22(3):218-229.

PMID: 38284696 DOI: 10.2174/0115701611283841231227064343.

Pharmacovariome scanning using whole pharmacogene resequencing coupled with deep computational analysis and machine learning for clinical pharmacogenomics.

Tafazoli A, Mikros J, Khaghani F, Alimardani M, Rafigh M, Hemmati M Hum Genomics. 2023; 17(1):62.

PMID: 37452347 PMC: 10347842. DOI: 10.1186/s40246-023-00508-1.

The Transition from Cancer "omics" to "epi-omics" through Next- and Third-Generation Sequencing.

Athanasopoulou K, Daneva G, Boti M, Dimitroulis G, Adamopoulos P, Scorilas A Life (Basel). 2022; 12(12).

PMID: 36556377 PMC: 9785810. DOI: 10.3390/life12122010.

Genetic Epidemiology of Medication Safety and Efficacy Related Variants in the Central Han Chinese Population With Whole Genome Sequencing.

Tian J, Zhang J, Yang Z, Feng S, Li S, Ren S Front Pharmacol. 2022; 12:790832.

PMID: 35280256 PMC: 8906509. DOI: 10.3389/fphar.2021.790832.

References

Rasmussen-Torvik L, Stallings S, Gordon A, Almoguera B, Basford M, Bielinski S . Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems. Clin Pharmacol Ther. 2014; 96(4):482-9. PMC: 4169732. DOI: 10.1038/clpt.2014.137. View

Motsinger-Reif A, Jorgenson E, Relling M, Kroetz D, Weinshilboum R, Cox N . Genome-wide association studies in pharmacogenomics: successes and lessons. Pharmacogenet Genomics. 2010; 23(8):383-94. PMC: 3003940. DOI: 10.1097/FPC.0b013e32833d7b45. View

Mooney S . Progress towards the integration of pharmacogenomics in practice. Hum Genet. 2014; 134(5):459-65. PMC: 4362928. DOI: 10.1007/s00439-014-1484-7. View

Drogemoller B, Wright G, Niehaus D, Emsley R, Warnich L . Whole-genome resequencing in pharmacogenomics: moving away from past disparities to globally representative applications. Pharmacogenomics. 2011; 12(12):1717-28. DOI: 10.2217/pgs.11.119. View

Mizzi C, Peters B, Mitropoulou C, Mitropoulos K, Katsila T, Agarwal M . Personalized pharmacogenomics profiling using whole-genome sequencing. Pharmacogenomics. 2014; 15(9):1223-34. DOI: 10.2217/pgs.14.102. View

Nekrutenko A, Taylor J . Next-generation sequencing data interpretation: enhancing reproducibility and accessibility. Nat Rev Genet. 2012; 13(9):667-72. DOI: 10.1038/nrg3305. View

Gamazon E, Skol A, Perera M . The limits of genome-wide methods for pharmacogenomic testing. Pharmacogenet Genomics. 2012; 22(4):261-72. PMC: 3655533. DOI: 10.1097/FPC.0b013e328350ca5f. View

Feero W . Clinical application of whole-genome sequencing: proceed with care. JAMA. 2014; 311(10):1017-9. DOI: 10.1001/jama.2014.1718. View

Neuraz A, Chouchana L, Malamut G, Le Beller C, Roche D, Beaune P . Phenome-wide association studies on a quantitative trait: application to TPMT enzyme activity and thiopurine therapy in pharmacogenomics. PLoS Comput Biol. 2014; 9(12):e1003405. PMC: 3873228. DOI: 10.1371/journal.pcbi.1003405. View

10.

Drogemoller B, Wright G, Niehaus D, Emsley R, Warnich L . Next-generation sequencing of pharmacogenes: a critical analysis focusing on schizophrenia treatment. Pharmacogenet Genomics. 2013; 23(12):666-74. DOI: 10.1097/FPC.0000000000000006. View

11.

Nelson M, Wegmann D, Ehm M, Kessner D, St Jean P, Verzilli C . An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people. Science. 2012; 337(6090):100-4. PMC: 4319976. DOI: 10.1126/science.1217876. View

12.

Kampourakis K, Vayena E, Mitropoulou C, van Schaik R, Cooper D, Borg J . Key challenges for next-generation pharmacogenomics: Science & Society series on Science and Drugs. EMBO Rep. 2014; 15(5):472-6. PMC: 4210086. DOI: 10.1002/embr.201438641. View

13.

Wang L, Weinshilboum R . Pharmacogenomics: candidate gene identification, functional validation and mechanisms. Hum Mol Genet. 2008; 17(R2):R174-9. PMC: 2574004. DOI: 10.1093/hmg/ddn270. View

14.

Meyerson M, Gabriel S, Getz G . Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet. 2010; 11(10):685-96. DOI: 10.1038/nrg2841. View

15.

Squassina A, Manchia M, Manolopoulos V, Artac M, Lappa-Manakou C, Karkabouna S . Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice. Pharmacogenomics. 2010; 11(8):1149-67. DOI: 10.2217/pgs.10.97. View

16.

Ardlie K, Kruglyak L, Seielstad M . Patterns of linkage disequilibrium in the human genome. Nat Rev Genet. 2002; 3(4):299-309. DOI: 10.1038/nrg777. View

17.

Pavlopoulos G, Oulas A, Iacucci E, Sifrim A, Moreau Y, Schneider R . Unraveling genomic variation from next generation sequencing data. BioData Min. 2013; 6(1):13. PMC: 3726446. DOI: 10.1186/1756-0381-6-13. View

18.

Potamias G, Lakiotaki K, Katsila T, Lee M, Topouzis S, Cooper D . Deciphering next-generation pharmacogenomics: an information technology perspective. Open Biol. 2014; 4(7). PMC: 4118603. DOI: 10.1098/rsob.140071. View

19.

Crews K, Hicks J, Pui C, Relling M, Evans W . Pharmacogenomics and individualized medicine: translating science into practice. Clin Pharmacol Ther. 2012; 92(4):467-75. PMC: 3589526. DOI: 10.1038/clpt.2012.120. View

20.

Ashley E, Butte A, Wheeler M, Chen R, Klein T, Dewey F . Clinical assessment incorporating a personal genome. Lancet. 2010; 375(9725):1525-35. PMC: 2937184. DOI: 10.1016/S0140-6736(10)60452-7. View